Upstanding, Legal, and Regulatory Issues

Richard Chin , Bruce Y. Lee , in Principles and Practise of Clinical Trial Medicine, 2008

two.3.1 Institutional Review Lath (IRB)/ Independent Ethics Committee (IEC)

An IRB [or independent ethics committee (IEC), as IRBs are referred to outside the United States and Canada] is a grouping officially responsible for reviewing and monitoring biomedical enquiry involving human being subjects and imbued with the power to approve, require alterations in, or disapprove clinical studies. The main purpose of the IRB is to safeguard the rights and welfare of homo subjects. Clinical studies cannot commence without IRB approval (or the IRB indicating that formal approval is non necessary). The IRB will non but review report protocols earlier studies begin only also periodically monitor clinical research as information technology progresses.

An institution does not have to have an IRB to engage in research. If you practice not belong to an institution with an IRB, you tin can establish formal relationships with an "outside" independent IRB (east.g., community hospital, university, contained IRB, or government agency) to oversee your research activities. If you lot cannot find an outside IRB, you can contact the FDA for assist. If your study is rejected by an independent IRB, you have the correct to submit it to another IRB but must provide the documentation from the beginning IRB that rejected your study (including the reasons for rejecting your study protocol). However, y'all may not have this recourse if your study is rejected by your institution'due south IRB.

Call back the primary purpose of an IRB is to protect study subjects, not the establishment or the investigator. An IRB should not refuse a study merely to protect the reputation of the institution (due east.g., a written report showing the number of medical mistakes occurring in a hospital) or take a study only because information technology may bring positive publicity for the establishment.

A researcher may be part of an IRB simply may non review any studies for which he or she may have a conflicting involvement (east.g., the researcher'southward report or a potential competitor). The IRB should have a reasonable amount of diverseness (due east.thousand., gender, race, ethnicity, scientific disciplines, and professional backgrounds) and consist of both scientists and nonscientists. While IRB members may be paid for their services, payment cannot in any way be tied to their decisions. Since members volition not always exist available, the IRB should formally appoint adequate alternates to make full in whenever an IRB member cannot attend a coming together.

When your clinical study involves minimal take chances to its subjects, you may request an expedited review, that is, the chairperson or certain designated members of the IRB may review and approve the study protocol without convening a formal meeting. This reviewer (or reviewers) has (or accept) all the power of the IRB except the correct to turn down a report protocol (the full committee must meet to do then). Minor changes in an existing IRB-canonical study protocol besides may qualify for expedited review.

The IRB has the right to detect (or designate someone else to notice) any part of your research process (eastward.grand., the subject recruitment and informed consent procedure). You should notify your IRB of patient agin events and any significant alter in your study protocol or procedures. The IRB must review and corroborate all amendments to the study protocol earlier the changes are implemented, unless an emergent protocol alter is needed to protect patients from imminent danger. You should inform patients of any changes that may touch their desire to participate in the study and give them the opportunity to withdraw from the report if they choose.

Read full chapter

URL:

https://www.sciencedirect.com/science/article/pii/B9780123736956000028

Stakeholder Views on Returning Research Results

Susanne B. Haga , Jennifer Q. Zhao , in Advances in Genetics, 2013

iv.2 IRBs

IRBs serve to protect the welfare of research participants, but it is not quite clear what their role is with respect to returning results. Despite the many recommendations that accept been developed, there is no national consensus policy, and thus, IRBs are left with developing their own institutional policy or adopting an existing prepare of recommendations deemed appropriate for their institution and community. A review of publicly available documents from IRB websites showed variability and sometimes conflicting statements with respect to the type of issue mentioned and institutional policy on (not)disclosure in informed consent templates or guidance documents (Simon, Shinkunas, Brandt, & Williams, 2012). However, the pocket-size number of reported IRB policies suggests that research institutions are struggling to develop policies on returning research results, leaving researchers unsure about how to accost the consequence, if at all (Kozanczyn, Collins, & Fernandez, 2007; MacNeil & Fernandez, 2006a). Indeed, nigh researchers in one study reported that they were unaware of their institution's policy regarding return of research results or believed that they did non have a specific policy available (Fernandez et al., 2013).

The beingness of an institutional policy may be impacted by the attitudes and interests of IRB chairs and members on the issue of returning results. 1 survey reported potent support of IRB chairs for returning results (MacNeil & Fernandez, 2006a). Lemke, Trinidad, Edwards, Starks, and Wiesner (2010) reported that 78% of individuals involved in human subjects protections (primarily IRB members) believed that researchers had an ethical obligation to return individual results with clinical significance. Similarly, findings of a survey of IRB members found that a high proportion agreed that individual results of clinical significance should be made available to research participants, but only if the participant has agreed to be recontacted about anticipated results or an incidental finding (Dressler et al., 2012). All the same, for an untreatable disease such every bit Alzheimer affliction, one study establish that IRB chairs were divided on whether results should be returned to participants (Wolf, Catania, Dolcini, Pollack, & Lo, 2008).

Alternatively, the lack of institutional policies may exist due to IRBs' incertitude regarding their exact role on returning results, perhaps perceiving themselves as more of an overseer or partner with researchers rather than the final arbiter on returning results for a given report (Dressler et al., 2012). Furthermore, if clinical utility is a required criterion for results to be returned to participants, IRBs may discover themselves in a position outside of their role of research oversight, and thus, their authorization is unclear (Dressler et al., 2012). Some accept suggested that IRBs need to take a more active function in reviewing studies to identify potential incidental findings that should be offered to research participants (Keane, 2008), whereas others accept suggested a collaborative approach between participants, IRBs, and researchers to determine the near appropriate policy for their local institution (Dressler, 2009; Dressler et al., 2012).

Read full chapter

URL:

https://www.sciencedirect.com/science/article/pii/B9780124077034000025

Regulatory Approval

Tom Brody Ph.D. , in Clinical Trials (2nd Edition), 2016

a Introduction to the IRB

An Institutional Review Board (IRB) is not used for routine medical intendance, just is required for research on human being subjects. The possibility of the need for an IRB is raised in the state of affairs where a "projection involves gathering or using specimens, tissue, cells, data, documents, or information about or derived from humans for purposes other than medical care" ( 65). An IRB must have a minimum of v members including a scientist, a nonscientist, and at least one person who is non affiliated with the IRB's supporting establishment. Members review the Clinical Study Protocol, informed consent, Investigator's Brochures, and whatsoever recruitment material. Following review and discussion, the IRB volition vote to approve, disapprove, or require modifications for each written report (66,67).

The IRB finds a footing in 21 CFR §56.201, which states that the IRB is, "whatsoever board, committee, or other group formally designated by an establishment to review, to approve the initiation of, and to conduct periodic review of, biomedical enquiry involving human subjects. The primary purpose of such review is to assure the protection of the rights and welfare of the human subjects."

Read total chapter

URL:

https://world wide web.sciencedirect.com/scientific discipline/article/pii/B9780128042175000333

Expert Clinical Practice and Good Laboratory Practice

Nathalie One thousand. Zgheib , ... Robert A. Co-operative , in Clinical and Translational Scientific discipline (2d Edition), 2017

Institutional Review Board

The IRB, as well known every bit independent ethics committee (IEC), is "an independent body constituted of medical, scientific, and non-scientific members, whose responsibility is to ensure the protection of the rights, safety and well-being of homo subjects involved in a trial. Among other things, its functions include reviewing, blessing, and providing continuous review of trial protocol, amendments and methods and cloth to be used in obtaining and documenting informed consent of trial subjects" (FDA, 1996). Federally funded human inquiry is required to have IRB review and approval. Nigh research institutions, professional organizations, and academic journals utilize the aforementioned requirements.

A sponsor can elect to utilise the local IRB of each of the study sites or an exterior (regional, national, or international) IRB depending on the written report complexity and the local institution's willingness to have an outside IRB peer view over research conducted within the institution.

Read full chapter

URL:

https://world wide web.sciencedirect.com/scientific discipline/commodity/pii/B9780128021019000156

Institutional Review Boards

ALISON WICHMAN , in Principles and Practise of Clinical Research (Second Edition), 2007

2.4.three Continuing Review of Research

IRBs are required to conduct standing review of canonical enquiry at to the lowest degree annually or sooner if they determine that the research presents significant physical, social, or psychological risks to subjects. Standing review is required to ensure IRBs, investigators, enquiry subjects, and the public that appropriate and ongoing measures are being taken to protect the rights and welfare of subjects. Requirements for what information investigators must submit to an IRB at the fourth dimension of its standing review vary. For example, in the Intramural Research Program (IRP) of the NIH, investigators are required to submit for review by the IRB a copy of the currently canonical protocol consent document; a concise summary of the protocol'south progress to date; the reason(s) for continuing the study; the gender/indigenous breakdown of subjects recruited to date; and any scientific developments that impact the protocol, peculiarly those that deal with take a chance(s), burdens, or benefits to individual subjects. Also, at the time of continuing review, protocol investigators must study whatsoever new equity, consultative, or other relationships with non-NIH entities that might present a real or apparent disharmonize of interest in the conduct of the protocol (run across Chapter xi). At its standing review, or at whatsoever other time, an IRB may suspend, alter, or end blessing of research that has been associated with serious harm to subjects or is non being conducted in accord with federal regulatory requirements, upstanding guidelines, and/or institutional policies.

Read full chapter

URL:

https://world wide web.sciencedirect.com/science/article/pii/B9780123694409500074

Clinical Trials

Robert M. Califf , in Clinical and Translational Science (2nd Edition), 2017

The Institutional Review Board

The IRB continues to play a central role in the comport of all types of clinical enquiry. Approval past an IRB is mostly required for any type of human subjects research, fifty-fifty if the research is non funded by an external source. The IRB should consist of physicians with expertise in clinical trials and nonphysicians expert in clinical enquiry, as well as representatives with expertise in medical ethics and representatives of the community in which the research is being conducted. As with the DSMC, the IRB function has come under scrutiny, peculiarly from government agencies charged with ensuring the protection of human being subjects.

Several types of studies are typically exempted from the IRB procedure, including studies of public beliefs, inquiry on educational practices, and studies of existing information in which research data cannot be linked to individual subjects. Surveys and interviews may also be exempted when the subjects are not identified and the data are unlikely to result in a lawsuit, financial loss, or reduced employability of the subject.

Read total affiliate

URL:

https://www.sciencedirect.com/science/article/pii/B978012802101900003X

Large Clinical Trials and Registries—Clinical Research Institutes

ROBERT M. CALIFF , in Principles and Practice of Clinical Research (2nd Edition), 2007

15.one.3 The Institutional Review Board

The institutional review board (IRB) continues to play a critical role in the conduct of all types of clinical research. Approval by the IRB is generally required for any type of research, fifty-fifty if the research is not funded by an external source. The IRB should consist of physicians with expertise in clinical trials besides equally representatives with expertise in medical ideals and representatives of gild in the customs in which the enquiry is being conducted. Equally with the DSMC, the IRB function has come under scrutiny, especially from government agencies charged with ensuring the protection of man subjects.

Several types of studies are typically exempted from the IRB process, including studies of public beliefs, research on educational practices, and studies of existing information in which the research data cannot exist linked to private subjects. Surveys and interviews may as well exist exempted when the subjects are not identified and the data accept a very low likelihood of leading to a lawsuit, fiscal loss, or reduced employability of the subject area.

Read total chapter

URL:

https://world wide web.sciencedirect.com/scientific discipline/article/pii/B9780123694409500220

Institutional Review Boards

Julia Slutsman , Lynnette Nieman , in Principles and Do of Clinical Research (Quaternary Edition), 2018

Standing Review of Research

IRBs are required to carry continuing review of approved enquiry at least annually, or sooner if they determine that the enquiry presents significant physical, social, or psychological risks to subjects (45 CFR 46.109(e)). Continuing review is required to assure IRBs, investigators, research subjects, and the public that ongoing assessment will protect the rights and welfare of subjects. Requirements regarding what information investigators must submit to an IRB at the fourth dimension of its continuing review vary according to institutional requirements and whether any subjects go on to be seen. For example, in the IRP of the NIH, investigators are required to submit materials including a copy of the currently approved protocol consent document; a curtailed summary of the protocol'southward progress to engagement; the reason(s) for continuing the study; the gender/ethnic breakup of subjects recruited to date; and any scientific developments that bear upon the protocol, particularly those that bargain with risk(due south), burdens, or benefits to individual subjects. As well, at the time of continuing review, protocol investigators must study any new disinterestedness, consultative, or other relationships with not-NIH entities that might present a existent or apparent disharmonize of involvement in the conduct of the protocol. By contrast, if no subjects continue to be seen, a more abbreviated and expedited procedure is possible.

At its standing review, or at whatever other time, an IRB may append, change, or finish approval of research that has been associated with serious harm to subjects or is not being conducted in accord with federal regulatory requirements, ethical guidelines, and/or institutional policies. The Final Dominion allows IRBs to not crave continuing review for enquiry that is no greater than minimal risk.

Read full chapter

URL:

https://www.sciencedirect.com/science/commodity/pii/B9780128499054000046

Adolescent Participation in Research

Lorah D. Dorn PhD , in Adolescent Medicine, 2008

Institutional Review Board (IRB)

The IRB is an administrative organ that is designed to protect the rights and welfare of individuals who are approached for research participation, every bit well every bit individuals who are participating in research. The IRB has the dominance to approve, disapprove, and regulate all enquiry within an establishment based on the federal guidelines mentioned previously. An IRB may exist within one institution (e.g., university, infirmary, medical centre) and serve only that establishment, or it may exist within the private sector and serve many institutions. Different estimation and awarding of the federal regulations across IRBs upshot in different allowable research practices across institutions. For example, some institutions never allow waiver of parental consent despite federal regulations allowing it in certain circumstances.

Read full chapter

URL:

https://www.sciencedirect.com/science/article/pii/B9780323040730100093

Clinical Study Conduct and Monitoring

Edda Gomez-Panzani , in Global Clinical Trials, 2011

19.10.1 Institutional Review Lath

The IRB (chosen the IEC in the European union) is composed of a group of at least five members (and a few alternatives) that ensures that the rights and welfare of humans participating as subjects in a inquiry study are maintained throughout the subjects' participation. To eliminate any diversity bias members must come from different disciplines [scientific (at least one md) and non-scientific (at least i non-scientific or layperson)] and ethnic backgrounds and both genders must be represented. The IRB membership usually consists of physicians, nurses, pharmacists, statisticians, an ethicist, and a patient abet. There are two primary types of IRBs, a key IRB and a local IRB.

Central IRBs oversee multicenter trials and are at a location unlike from the clinical study sites. They tin can exist established by public agencies [such as the National Institutes of Health (NIH)] or by individual enterprises. They usually come across every week or two weeks and on occasion will agree to an unscheduled meeting if the lack of a prompt IRB blessing could considerably filibuster the clinical study timelines.

Local IRBs are affiliated with the establishment or study site that is conducting the clinical written report (e.g. medical center, university) and are commonly located at the same institution or study site. They usually meet less frequently than the central IRBs (once a month or even once every ii months). This can upshot in lengthy approval times, especially if revisions are required later on the first review and the documents have to be resubmitted for review at the next scheduled meeting.

Information technology is very important to select an IRB properly. Some researchers take evaluated unlike IRBs and have found inconsistencies in both their review processes and their recommendations [1,seven]; therefore, to preclude selection bias and to make the review procedure more than efficient, it is appropriate whenever possible to utilise ane very experienced, single, qualified central IRB for the review of all documents. Occasionally, a local IRB will be preferred (e.g. for a single-center study) or required (some institutions, especially medical centers affiliated to academic institutions volition not participate in whatsoever clinical research study that has not been approved by their own IRB). Either one is acceptable as long as such IRB has a clear understanding regarding the context of the study and the values of the community where the research is taking place.

When evaluating an IRB information technology helps to keep in heed the summit IRB deficiencies identified past the CDER for the financial year 2009 [eight] (Figure 19.i).

Figure 19.1. Top institutional review board deficiencies as per Center for Drug Evaluation and Inquiry, fiscal year 2009. NAI: No Action Indicated

 (With permission from Barnett International [viii]). (Delight refer to color plate section)

No enquiry involving man subjects can commence without IRB blessing except for research that involves the collection and assay of existing information (eastward.g. records, biological and medical specimens) and where the subjects to which the information pertains cannot be identified.

Documents that require IRB approving include, but are not express to, the clinical study protocol, written report-specific informed consent, referral letters to be used during the written report, investigator brochure (IB) and patient information brochure. The ICH-GCP guidelines describe the IB equally "a compilation of the clinical and nonclinical data on the investigational product(southward) that are relevant to the study of the product(s) in human subjects".

Approval should be obtained not only before the bear of the clinical written report, but besides at any time whatsoever changes are made to the documents already approved by the IRB or if whatsoever new documents related to study-specific activities are generated.

The IRB will continue to review the study on an ongoing basis. The frequency with which the IRB chooses to receive updates is determined by the perceived run a risk to the subjects/patients; however, an annual report is expected throughout the elapsing of the study. Serious/life-threatening adverse events (SAEs) must also be reported to the IRB. During monitoring, ensuring that all SAE reports accept been forwarded to the IRB is of utmost importance.

All IRBs take the authority to approve, crave modifications (to secure blessing), or disapprove research [9], and are subject to the rules and guidelines outlined by the U.s. Department of Health and Man Services' Function for Human Enquiry Protections (OHRP) and the FDA.

After completion of the study, a final written report providing a summary of the final enrollment numbers, adverse event summaries and updates, as well as the conclusions of the written report (as available) must be submitted to the IRB.

Read full chapter

URL:

https://world wide web.sciencedirect.com/science/article/pii/B9780123815378100196